doi:10.3389/fendo.2022.945609 35
Introduction Multisystemic inflammatory syndrome in children (MIS-C) that is temporarily associated with the novel coronavirus disease 2019 (COVID-19) has been recently described as an inflammatory complication after exposure to the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), with the possibility of serious and lethal complications, including coronary aneurysm ( This article describes the complete clinical course and follow-up data of a 7-year-old child treated at a pediatric intensive care unit (PICU) with severe MIS-C with coronary aneurysm, who was treated with human intravenous immunoglobulin (IVIG) and acetylsalicylic acid (ASA)
Cannabis smoke contains many of the same irritants, toxins, and cancer-causing agents as tobacco smoke, according to the American Lung Association
2013A glucagon-like peptide-1 analog reverses the molecular pathology and cardiac dysfunction of a mouse model of obesity
(October 18, 2025) Evaluation of Polmacoxib 2 mg for the Management of Hip and Knee Osteoarthritis: A Prospective, Single-Arm, Multicenter, Open-Label Study
Both melatonin and GLP-1 receptor agonists can influence glucose metabolism, though through different mechanisms
